Trial | NCT01987999  Report issue

Title

Eradication of Prostate Cancer Using F-989
Phase II Eradication of Prostate Cancer Using F-989

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    60
The purpose of this study is to confirm the findings of an early study with prostate cancer and to expand our knowledge of treating prostate cancer using F-989.
Study Started
Feb 28
2013
Primary Completion
Dec 31
2015
Study Completion
Dec 31
2015
Last Update
Sep 20
2019

Dietary Supplement Acetogenins

Acetogenins Experimental

Acetogenins twice (BID) per day for 12 months

Criteria 

Inclusion Criteria:

Clinical diagnosis of prostate cancer
Referred to the study by their treating physician

Exclusion Criteria:

- Any type of treatment before starting study
No Results Posted